Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

In Reply to Halperin.

Scheinman SJ.

Acad Med. 2019 May;94(5):613. doi: 10.1097/ACM.0000000000002660. No abstract available.

PMID:
31021866
2.

Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.

Beara-Lasic L, Cogal A, Mara K, Enders F, Mehta RA, Haskic Z, Furth SL, Trachtman H, Scheinman SJ, Milliner DS, Goldfarb DS, Harris PC, Lieske JC; investigators of the Rare Kidney Stone Consortium.

Pediatr Nephrol. 2019 Mar 10. doi: 10.1007/s00467-019-04210-0. [Epub ahead of print]

PMID:
30852663
3.

Oath Taking at U.S. and Canadian Medical School Ceremonies: Historical Perspectives, Current Practices, and Future Considerations.

Scheinman SJ, Fleming P, Niotis K.

Acad Med. 2018 Sep;93(9):1301-1306. doi: 10.1097/ACM.0000000000002097.

PMID:
29239902
4.

Glomerular Pathology in Dent Disease and Its Association with Kidney Function.

Wang X, Anglani F, Beara-Lasic L, Mehta AJ, Vaughan LE, Herrera Hernandez L, Cogal A, Scheinman SJ, Ariceta G, Isom R, Copelovitch L, Enders FT, Del Prete D, Vezzoli G, Paglialonga F, Harris PC, Lieske JC; Investigators of the Rare Kidney Stone Consortium.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2168-2176. Epub 2016 Oct 3.

5.

Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.

Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ Jr, Hodanová K, Vylet'al P, Živná M, Hart TC, Hart PS.

Clin J Am Soc Nephrol. 2014 Mar;9(3):527-35. doi: 10.2215/CJN.06380613. Epub 2014 Feb 7.

6.

Effects of Sex on Intra-Individual Variance in Urinary Solutes in Stone-Formers Collected from a Single Clinical Laboratory.

Perry GM, Scheinman SJ, Asplin JR.

PLoS One. 2013 Jun 19;8(6):e53637. doi: 10.1371/journal.pone.0053637. Print 2013.

7.

Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations.

Jaureguiberry G, De la Dure-Molla M, Parry D, Quentric M, Himmerkus N, Koike T, Poulter J, Klootwijk E, Robinette SL, Howie AJ, Patel V, Figueres ML, Stanescu HC, Issler N, Nicholson JK, Bockenhauer D, Laing C, Walsh SB, McCredie DA, Povey S, Asselin A, Picard A, Coulomb A, Medlar AJ, Bailleul-Forestier I, Verloes A, Le Caignec C, Roussey G, Guiol J, Isidor B, Logan C, Shore R, Johnson C, Inglehearn C, Al-Bahlani S, Schmittbuhl M, Clauss F, Huckert M, Laugel V, Ginglinger E, Pajarola S, Spartà G, Bartholdi D, Rauch A, Addor MC, Yamaguti PM, Safatle HP, Acevedo AC, Martelli-Júnior H, dos Santos Netos PE, Coletta RD, Gruessel S, Sandmann C, Ruehmann D, Langman CB, Scheinman SJ, Ozdemir-Ozenen D, Hart TC, Hart PS, Neugebauer U, Schlatter E, Houillier P, Gahl WA, Vikkula M, Bloch-Zupan A, Bleich M, Kitagawa H, Unwin RJ, Mighell A, Berdal A, Kleta R.

Nephron Physiol. 2012;122(1-2):1-6. doi: 10.1159/000349989. Epub 2013 Feb 23.

8.

Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.

Kirby A, Gnirke A, Jaffe DB, Barešová V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, Hůlková H, Sovová J, Vylet'al P, Antignac C, Guttman M, Handsaker RE, Perrin D, Steelman S, Sigurdsson S, Scheinman SJ, Sougnez C, Cibulskis K, Parkin M, Green T, Rossin E, Zody MC, Xavier RJ, Pollak MR, Alper SL, Lindblad-Toh K, Gabriel S, Hart PS, Regev A, Nusbaum C, Kmoch S, Bleyer AJ, Lander ES, Daly MJ.

Nat Genet. 2013 Mar;45(3):299-303. doi: 10.1038/ng.2543. Epub 2013 Feb 10.

9.

In memoriam: Oliver M. Wrong.

Scheinman SJ, Feehally J, Feest TG, Norden AG, Thakker RV, Unwin RJ.

Kidney Int. 2012 Jul;82(2):121-2. doi: 10.1038/ki.2012.183. No abstract available.

10.

Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus).

Perry GM, Nehrke KW, Bushinsky DA, Reid R, Lewandowski KL, Hueber P, Scheinman SJ.

Genetics. 2012 Jul;191(3):1003-13. doi: 10.1534/genetics.112.138909. Epub 2012 May 2.

11.

Weight, age and coefficients of variation in renal solute excretion.

Perry GM, Scheinman SJ, Asplin JR.

Nephron Physiol. 2012;122(1-2):13-8. doi: 10.1159/000346148. Epub 2013 Mar 19.

PMID:
23595094
12.

Inherited cerebrorenal syndromes.

Schurman SJ, Scheinman SJ.

Nat Rev Nephrol. 2009 Sep;5(9):529-38. doi: 10.1038/nrneph.2009.124. Review.

PMID:
19701229
13.

OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability.

Shrimpton AE, Hoopes RR Jr, Knohl SJ, Hueber P, Reed AA, Christie PT, Igarashi T, Lee P, Lehman A, White C, Milford DV, Sanchez MR, Unwin R, Wrong OM, Thakker RV, Scheinman SJ.

Nephron Physiol. 2009;112(2):p27-36. doi: 10.1159/000213506. Epub 2009 Apr 18.

PMID:
19390221
14.

A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction.

Gailly P, Jouret F, Martin D, Debaix H, Parreira KS, Nishita T, Blanchard A, Antignac C, Willnow TE, Courtoy PJ, Scheinman SJ, Christensen EI, Devuyst O.

Kidney Int. 2008 Jul;74(1):52-61. doi: 10.1038/sj.ki.5002794. Epub 2008 Mar 5.

15.

Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats.

Hoopes RR Jr, Middleton FA, Sen S, Hueber PA, Reid R, Bushinsky DA, Scheinman SJ.

J Am Soc Nephrol. 2006 May;17(5):1292-304. Epub 2006 Apr 12.

16.

Dent Disease with mutations in OCRL1.

Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ.

Am J Hum Genet. 2005 Feb;76(2):260-7. Epub 2004 Dec 30. Erratum in: Am J Hum Genet. 2007 Sep;81(3):634.

17.

A cluster of metabolic defects caused by mutation in a mitochondrial tRNA.

Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP.

Science. 2004 Nov 12;306(5699):1190-4. Epub 2004 Oct 21.

18.

Evidence for genetic heterogeneity in Dent's disease.

Hoopes RR Jr, Raja KM, Koich A, Hueber P, Reid R, Knohl SJ, Scheinman SJ.

Kidney Int. 2004 May;65(5):1615-20.

19.
20.

Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease.

Hoopes RR Jr, Reid R, Sen S, Szpirer C, Dixon P, Pannett AA, Thakker RV, Bushinsky DA, Scheinman SJ.

J Am Soc Nephrol. 2003 Jul;14(7):1844-50.

21.

Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patients.

Moulin P, Igarashi T, Van der Smissen P, Cosyns JP, Verroust P, Thakker RV, Scheinman SJ, Courtoy PJ, Devuyst O.

Kidney Int. 2003 Apr;63(4):1285-95.

22.

Nephrolithiasis, osteoporosis, and mutations in the type 2a sodium-phosphate cotransporter.

Scheinman SJ, Tenenhouse HS.

N Engl J Med. 2003 Jan 16;348(3):264-5; author reply 264-5. No abstract available.

PMID:
12529474
23.

Responsiveness of hypercalciuria to thiazide in Dent's disease.

Raja KA, Schurman S, D'mello RG, Blowey D, Goodyer P, Van Why S, Ploutz-Snyder RJ, Asplin J, Scheinman SJ.

J Am Soc Nephrol. 2002 Dec;13(12):2938-44.

24.

Fragmentation of filtered proteins and implications for glomerular protein sieving in Fanconi syndrome.

Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, Thakker RV, Unwin RJ, Wrong O.

Kidney Int. 2002 Jul;62(1):349. No abstract available.

25.

Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome.

Norden AG, Lapsley M, Igarashi T, Kelleher CL, Lee PJ, Matsuyama T, Scheinman SJ, Shiraga H, Sundin DP, Thakker RV, Unwin RJ, Verroust P, Moestrup SK.

J Am Soc Nephrol. 2002 Jan;13(1):125-33.

26.

Glomerular protein sieving and implications for renal failure in Fanconi syndrome.

Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, Thakker RV, Unwin RJ, Wrong O.

Kidney Int. 2001 Nov;60(5):1885-92.

27.

New insights into causes and treatments of kidney stones.

Scheinman SJ.

Hosp Pract (1995). 2000 Mar 15;35(3):49-50, 53-6, 62-3 passim. Review.

PMID:
10737240
28.

Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases.

Norden AG, Scheinman SJ, Deschodt-Lanckman MM, Lapsley M, Nortier JL, Thakker RV, Unwin RJ, Wrong O.

Kidney Int. 2000 Jan;57(1):240-9.

29.

Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria.

Scheinman SJ, Cox JP, Lloyd SE, Pearce SH, Salenger PV, Hoopes RR, Bushinsky DA, Wrong O, Asplin JR, Langman CB, Norden AG, Thakker RV.

Kidney Int. 2000 Jan;57(1):232-9.

30.

Nephrolithiasis.

Scheinman SJ.

Semin Nephrol. 1999 Jul;19(4):381-8. Review.

PMID:
10435676
31.

Genetic disorders of renal electrolyte transport.

Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG.

N Engl J Med. 1999 Apr 15;340(15):1177-87. Review. No abstract available.

PMID:
10202170
32.

Divergence between stone composition and urine supersaturation: clinical and laboratory implications.

Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL.

J Urol. 1999 Apr;161(4):1077-81.

PMID:
10081841
33.

Clinical features of X-linked nephrolithiasis in childhood.

Langlois V, Bernard C, Scheinman SJ, Thakker RV, Cox JP, Goodyer PR.

Pediatr Nephrol. 1998 Oct;12(8):625-9.

PMID:
9811383
34.

Medical reduction of stone risk in a network of treatment centers compared to a research clinic.

Lingeman J, Mardis H, Kahnoski R, Goldfarb DS, Lacy S, Grasso M, Scheinman SJ, Parks JH, Asplin JR, Coe FL.

J Urol. 1998 Nov;160(5):1629-34.

PMID:
9783920
35.

CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis.

Hoopes RR Jr, Hueber PA, Reid RJ Jr, Braden GL, Goodyer PR, Melnyk AR, Midgley JP, Moel DI, Neu AM, VanWhy SK, Scheinman SJ.

Kidney Int. 1998 Sep;54(3):698-705.

36.

X-linked recessive nephrolithiasis: presentation and diagnosis in children.

Schurman SJ, Norden AG, Scheinman SJ.

J Pediatr. 1998 May;132(5):859-62.

PMID:
9602200
37.

X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations.

Scheinman SJ.

Kidney Int. 1998 Jan;53(1):3-17. Review. No abstract available.

38.

Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders.

Lloyd SE, Gunther W, Pearce SH, Thomson A, Bianchi ML, Bosio M, Craig IW, Fisher SE, Scheinman SJ, Wrong O, Jentsch TJ, Thakker RV.

Hum Mol Genet. 1997 Aug;6(8):1233-9.

PMID:
9259268
39.

A Pst I restriction fragment length polymorphism near the MAO locus on Xp.

Salenger PV, Hueber P, Speller PJ, Van Duijnhoven G, Hoopes RR Jr, Thakker RV, Berger W, Scheinman SJ.

Ann Hum Genet. 1996 Sep;60(5):437. No abstract available.

PMID:
8912796
40.

A common molecular basis for three inherited kidney stone diseases.

Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV.

Nature. 1996 Feb 1;379(6564):445-9.

PMID:
8559248
41.

Characterization of carrier females and affected males with X-linked recessive nephrolithiasis.

Reinhart SC, Norden AG, Lapsley M, Thakker RV, Pang J, Moses AM, Frymoyer PA, Favus MJ, Hoepner JA, Scheinman SJ.

J Am Soc Nephrol. 1995 Jan;5(7):1451-61.

42.

Acute interstitial nephritis with renal failure associated with propylthiouracil therapy.

Reinhart SC, Moses AM, Cleary L, Scheinman SJ.

Am J Kidney Dis. 1994 Oct;24(4):575-7.

PMID:
7942812
43.

Transepithelial phosphate transport in rabbit proximal tubular cells adapted to phosphate deprivation.

Scheinman SJ, Reid R, Coulson R, Jones DB, Ford SM.

Am J Physiol. 1994 Jun;266(6 Pt 1):C1609-18.

PMID:
8023892
44.

Localization of the Tamm-Horsfall glycoprotein (uromodulin) gene to chromosome 16p12.3-16p13.11.

Pook MA, Jeremiah S, Scheinman SJ, Povey S, Thakker RV.

Ann Hum Genet. 1993 Oct;57(4):285-90.

PMID:
8179291
45.

Hereditary vasopressin resistance in man and mouse.

Moses AM, Scheinman SJ.

Ann N Y Acad Sci. 1993 Jul 22;689:233-49. Review.

PMID:
8373015
46.

Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies.

Scheinman SJ, Pook MA, Wooding C, Pang JT, Frymoyer PA, Thakker RV.

J Clin Invest. 1993 Jun;91(6):2351-7.

47.

Effects of atrial natriuretic peptides on metabolism of arginine vasopressin by isolated perfused rat kidney.

Lebowitz MR, Moses AM, Scheinman SJ.

Am J Physiol. 1992 Aug;263(2 Pt 2):R273-8.

PMID:
1387294
48.

X-linked recessive nephrolithiasis with renal failure.

Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET.

N Engl J Med. 1991 Sep 5;325(10):681-6.

49.

Ectopic secretion of neurohypophyseal peptides in patients with malignancy.

Moses AM, Scheinman SJ.

Endocrinol Metab Clin North Am. 1991 Sep;20(3):489-506. Review.

PMID:
1935917
50.

Adenosine stimulates phosphate and glucose transport in opossum kidney epithelial cells.

Coulson R, Johnson RA, Olsson RA, Cooper DR, Scheinman SJ.

Am J Physiol. 1991 Jun;260(6 Pt 2):F921-8.

PMID:
1647692

Supplemental Content

Loading ...
Support Center